-Search query
-Search result
Showing 1 - 50 of 71 items for (author: kayama & y)
EMDB-36724:
Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 1)
Method: single particle / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36726:
Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 2)
Method: single particle / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36727:
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state)
Method: single particle / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36728:
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state)
Method: single particle / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36729:
Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2
Method: single particle / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-35622:
SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-35623:
SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-35624:
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-35625:
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (2-up state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-35626:
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 focused on RBD-ACE2 interface
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8ios:
Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8iot:
Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8iou:
Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8iov:
Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-34428:
Cryo-EM structure of the TnpB-omegaRNA-target DNA ternary complex
Method: single particle / : Nakagawa R, Hirano H, Omura S, Nureki O
PDB-8h1j:
Cryo-EM structure of the TnpB-omegaRNA-target DNA ternary complex
Method: single particle / : Nakagawa R, Hirano H, Omura S, Nureki O
EMDB-33059:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
Method: single particle / : Kamada K, Shirouzu M
EMDB-33060:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
Method: single particle / : Kamada K, Shirouzu M
EMDB-33061:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
Method: single particle / : Kamada K, Shirouzu M
EMDB-33062:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
Method: single particle / : Kamada K, Shirouzu M
EMDB-33063:
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
Method: single particle / : Kamada K, Shirouzu M
EMDB-33064:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8w:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8y:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8z:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
Method: single particle / : Kamada K, Shirouzu M
PDB-7x90:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
Method: single particle / : Kamada K, Shirouzu M
PDB-7x91:
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
Method: single particle / : Kamada K, Shirouzu M
PDB-7x92:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
Method: single particle / : Kamada K, Shirouzu M
EMDB-34221:
SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-34222:
SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 2)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-34223:
SARS-CoV-2 BA.2.75 spike glycoprotein (1-up state)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-34224:
SARS-CoV-2 BA.2.75 spike glycoprotein in complex with ACE2
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
PDB-8gs6:
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-32071:
A tomogram of medusaviruses outside the host cell by cryo-electron tomography
Method: electron tomography / : Murata K, Song C, Watanabe R
EMDB-32072:
Cryo-EM structure of Empty medusavirus particle
Method: single particle / : Murata K, Song C, Watanabe R
EMDB-32073:
Cryo-EM structure of DNA-Full medusavirus particle
Method: single particle / : Murata K, Song C, Watanabe R
EMDB-30915:
Apo spike protein of SARS-CoV2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30916:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody 8D2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30917:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-1
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30918:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30919:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-3
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30920:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (8D2)-4
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30921:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (2940)-1
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
EMDB-30922:
SARS-CoV2 spike protein with Fab fragment of enhancing antibody (2940)-2
Method: single particle / : Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
PDB-7dzw:
Apo spike protein from SARS-CoV2
Method: single particle / : Liu Y, Soh WT, Li S, Kishikawa J, Hirose M, Kato T, Standley D, Okada M, Arase H
PDB-7dzx:
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2
Method: single particle / : Liu Y, Soh WT, Li S, Kishikawa J, Hirose M, Kato T, Standley D, Okada M, Arase H
PDB-7dzy:
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490
Method: single particle / : Liu Y, Soh WT, Li S, Kishikawa J, Hirose M, Kato T, Standley D, Okada M, Arase H
EMDB-30095:
3.6A beta-galactosidase using JEM-2100F + K2 Summit, SerialEM acquisition, RELION 3.0 processing.
Method: single particle / : Burton-Smith RN, Kayama Y, Song C, Kato T, Murata K
EMDB-30096:
3A Apoferritin, JEM-2100F + K2 Summit, 50K, RELION 3.1
Method: single particle / : Burton-Smith RN, Kayama Y, Song C, Kato T, Murata K
EMDB-30097:
3.3A apoferritin from JEM-2100F + K2 Summit at 50K with symmetry expansion.
Method: single particle / : Burton-Smith RN, Kayama Y, Song C, Kato T, Murata K
Pages: